Researchers from Western University recently made a splash with news that a HIV vaccine (SAV001) has made its way through initial clinical trials, and will be now tested on humans.
“We were very excited with the Phase I results,” the researchers say. “The trial demonstrated that our vaccine stimulates broadly neutralizing antibodies that will neutralize not only single sub-types of HIV, but other sub-types, which means that you can have the vaccine cover many different strains of the virus.”
Despite this apparent progress however, there is still clearly much to be done to tackle a disease that affects some 17 million people around the world. This number remains high despite the number of people being infected by the HIV virus actually going down, with this apparent dichotomy largely because a cocktail of treatments is able to keep patients alive for longer.